Literature DB >> 10858460

Alternative translation initiation of human fibroblast growth factor 2 mRNA controlled by its 3'-untranslated region involves a Poly(A) switch and a translational enhancer.

C Touriol1, M Roussigne, M C Gensac, H Prats, A C Prats.   

Abstract

Five fibroblast growth factor 2 (FGF-2) isoforms are synthesized from human FGF-2 mRNA by a process of alternative initiation of translation. The regulation of FGF-2 isoform expression by the mRNA 5823-nucleotide-long 3'-untranslated region containing eight alternative polyadenylation sites was examined. Because previous studies had shown that FGF-2 expression was regulated in primary cells but not in transformed cells, primary human skin fibroblasts were used in this study. Using an approach of cell transfection with synthetic reporter mRNAs, a novel translational enhancer (3'-TE) was identified in the 1370-nucleotide mRNA segment located upstream from the eighth poly(A) site. Deletion mutagenesis showed that the 3'-TE was composed of two domains with additive effects. The 3'-TE exhibited the unique feature of modulating the use of FGF-2 alternative initiation codons, which favored the relative expression of CUG-initiated isoforms. Interestingly, the use of an alternative polydenylation site removing the 3'-TE was detected in skin fibroblasts in response to heat shock and cell density variations. At high cell densities, 3'-TE removal was correlated with a loss of CUG-initiated FGF-2 expression. These data show that the FGF-2 mRNA 3'-untranslated region is able to modulate FGF-2 isoform expression by the coupled processes of translation activation and alternative polyadenylation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10858460     DOI: 10.1074/jbc.M908431199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  The disparate nature of "intergenic" polyadenylation sites.

Authors:  Fabrice Lopez; Samuel Granjeaud; Takeshi Ara; Badih Ghattas; Daniel Gautheret
Journal:  RNA       Date:  2006-08-24       Impact factor: 4.942

Review 2.  A nuclear odyssey: fibroblast growth factor-2 (FGF-2) as a regulator of nuclear homeostasis in the nervous system.

Authors:  Benjamin Förthmann; Claudia Grothe; Peter Claus
Journal:  Cell Mol Life Sci       Date:  2015-01-01       Impact factor: 9.261

3.  Essential role of bone marrow fibroblast growth factor-2 in the effect of estradiol on reendothelialization and endothelial progenitor cell mobilization.

Authors:  Vincent Fontaine; Cédric Filipe; Nikos Werner; Pierre Gourdy; Audrey Billon; Barbara Garmy-Susini; Laurent Brouchet; Francis Bayard; Hervé Prats; Thomas Doetschman; Georg Nickenig; Jean-François Arnal
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

Review 4.  High molecular weight FGF2: the biology of a nuclear growth factor.

Authors:  K Chlebova; V Bryja; P Dvorak; A Kozubik; W R Wilcox; P Krejci
Journal:  Cell Mol Life Sci       Date:  2009-01       Impact factor: 9.261

5.  An upstream open reading frame within an IRES controls expression of a specific VEGF-A isoform.

Authors:  Amandine Bastide; Zeineb Karaa; Stéphanie Bornes; Corinne Hieblot; Eric Lacazette; Hervé Prats; Christian Touriol
Journal:  Nucleic Acids Res       Date:  2008-02-26       Impact factor: 16.971

Review 6.  Circular RNA, the Key for Translation.

Authors:  Anne-Catherine Prats; Florian David; Leila H Diallo; Emilie Roussel; Florence Tatin; Barbara Garmy-Susini; Eric Lacazette
Journal:  Int J Mol Sci       Date:  2020-11-14       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.